JPH0222076B2 - - Google Patents

Info

Publication number
JPH0222076B2
JPH0222076B2 JP53053311A JP5331178A JPH0222076B2 JP H0222076 B2 JPH0222076 B2 JP H0222076B2 JP 53053311 A JP53053311 A JP 53053311A JP 5331178 A JP5331178 A JP 5331178A JP H0222076 B2 JPH0222076 B2 JP H0222076B2
Authority
JP
Japan
Prior art keywords
thienamycin
compounds
salts
agents
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP53053311A
Other languages
English (en)
Japanese (ja)
Other versions
JPS53137992A (en
Inventor
Jii Kurisutensen Baaton
Jee Reenza Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS53137992A publication Critical patent/JPS53137992A/ja
Publication of JPH0222076B2 publication Critical patent/JPH0222076B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP5331178A 1977-05-05 1978-05-06 Nnalkyllnnacyl derivative of thienamycine Granted JPS53137992A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/793,974 US4235917A (en) 1977-05-05 1977-05-05 N-Alkyl-N-acyl derivatives of thienamycin

Publications (2)

Publication Number Publication Date
JPS53137992A JPS53137992A (en) 1978-12-01
JPH0222076B2 true JPH0222076B2 (OSRAM) 1990-05-17

Family

ID=25161301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5331178A Granted JPS53137992A (en) 1977-05-05 1978-05-06 Nnalkyllnnacyl derivative of thienamycine

Country Status (14)

Country Link
US (1) US4235917A (OSRAM)
JP (1) JPS53137992A (OSRAM)
BE (1) BE866660A (OSRAM)
CH (1) CH638209A5 (OSRAM)
DE (1) DE2819479A1 (OSRAM)
DK (1) DK170678A (OSRAM)
ES (1) ES469425A1 (OSRAM)
FR (1) FR2389629B1 (OSRAM)
GB (1) GB1604276A (OSRAM)
IE (1) IE46877B1 (OSRAM)
IT (1) IT1105291B (OSRAM)
LU (1) LU79597A1 (OSRAM)
NL (1) NL7804230A (OSRAM)
SE (1) SE7804446L (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839352A (en) * 1975-11-21 1989-06-13 Merck & Co., Inc. N-acyl derivatives of thienamycin
US4318912A (en) * 1979-01-02 1982-03-09 Merck & Co., Inc. 6-(1-Hydroxyethyl)-3-substituted-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
EP0024832B1 (en) * 1979-08-10 1985-03-13 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
US4361512A (en) * 1980-11-26 1982-11-30 Merck & Co., Inc. 2-Substituted thio-6-substituted-carbapen-2-em-3-carboxylic acids
JPS5857392A (ja) * 1981-10-02 1983-04-05 Sanraku Inc 新規な抗生物質ｏａ−６１２９のリン酸エステル
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
ZA832412B (en) * 1982-04-09 1983-12-28 Bristol Myers Co Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4529597A (en) * 1982-04-19 1985-07-16 Merck & Co., Inc. Substituted 1-azabicyclo(3.2.0)hept-6-en-2-one-7-carboxylic acids
BE897086A (fr) * 1982-06-18 1983-12-19 Bristol Myers Co Produits nouveaux de la classe des carbapenems et leur application en tant qu'antibiotiques
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
ZM1484A1 (en) * 1983-03-08 1984-12-21 Bristol Myers Co Carbapenem process
US4992542A (en) * 1984-01-24 1991-02-12 Merck & Co., Inc. 2-substituted-6-carbadethiapen-2-em-3-carboxylic acids
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
CH632508A5 (de) * 1975-11-21 1982-10-15 Merck & Co Inc Verfahren zur herstellung von neuen estern des n-acylierten thienamycins.
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone

Also Published As

Publication number Publication date
IE46877B1 (en) 1983-10-19
DE2819479C2 (OSRAM) 1992-04-30
LU79597A1 (fr) 1979-02-02
FR2389629B1 (OSRAM) 1980-06-20
IE780899L (en) 1978-11-05
NL7804230A (nl) 1978-11-07
ES469425A1 (es) 1980-01-01
IT7849175A0 (it) 1978-05-03
JPS53137992A (en) 1978-12-01
IT1105291B (it) 1985-10-28
DK170678A (da) 1979-01-16
SE7804446L (sv) 1978-11-06
FR2389629A1 (OSRAM) 1978-12-01
CH638209A5 (de) 1983-09-15
GB1604276A (en) 1981-12-09
DE2819479A1 (de) 1978-11-16
US4235917A (en) 1980-11-25
BE866660A (fr) 1978-11-03

Similar Documents

Publication Publication Date Title
US4168314A (en) 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid
JPH0222076B2 (OSRAM)
US4840944A (en) Antibacterial beta-lactams, pharmaceuticals thereof and methods of using them
JPH05509089A (ja) セファロスポリンおよび同族体、製法および医薬組成物
JPH0340030B2 (OSRAM)
US4301074A (en) 6-(1'-Hydroxyethyl)-2-substituted-pen-2-em-3-carboxylic acid
US4189493A (en) N-heterocyclic derivatives of thienamycin
US4218459A (en) 6-Amido-1-carba-2-penem-3-carboxylic acid
KR910002099B1 (ko) β-락탐 항생물질의 제조 방법
JPH0140837B2 (OSRAM)
US4123539A (en) 6-Ethylpenicillanic acid
US4263302A (en) Quinolinecarboxylic acid substituted penicillins and pharmaceutical compositions containing the same
JPH0145473B2 (OSRAM)
US4374848A (en) 6-(1-Hydroxyethyl)cyclonocardicin
CA1284993C (en) Cephalosporins and processes for their preparation
JPS6259107B2 (OSRAM)
US4172895A (en) 6-(1'-Hydroxyethyl)-2-aminoethylthio-oxapen-2-em-3-carboxylic acid
HU200778B (en) Process for producing new cefemcarboxylic acid derivatives and pharmaceutical compositions comprising such compounds
US4277482A (en) 3-Substituted thio-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid s-oxides
DE3833693A1 (de) Stabile oxapenem-3-carbonsaeuren und ihre verwendung als ss-lactamasehemmer
RU2201933C2 (ru) Антибактериальные замещенные 7-ациламино-3-(метилгидразоно)метилцефалоспорины, способ их получения, фармацевтические композиции на их основе, промежуточные соединения и способ лечения заболеваний, вызванных микроорганизмами
US6482818B2 (en) C-2 S/O-and S/N formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and β-lactamase inhibitors
EP0001516A1 (en) Beta-Lactam compounds, processes for their preparation, pharmaceutical compositions containing them and intermediates of use in their preparation
CA1150726A (en) Cephalosporins, processes for the preparation and pharmaceuticals containing these compounds
US4372965A (en) 6-, 1- And 2-substituted-thio-1-carbadethiapen-2-em-3-carboxylic acid S-oxides